We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Celgene's Bid To Trim Drug Monopoly Suit Denied

Law360 (November 1, 2018, 7:44 PM EDT) -- A suit accusing biopharmaceutical firm Celgene Corp. of locking two competing generic drugs out of the market remains intact in New Jersey federal court, after a judge has refused to toss...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New Jersey

Nature of Suit

Anti-Trust

Judge

Subscribers Only

Date Filed

November 7, 2014

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.